
|Videos|January 8, 2018
Could COX-2 Inhibition With Celecoxib Have Role in Breast Cancer?
Author(s)R. Charles Coombes, MD, PhD
This video highlights results of REACT, a phase III multi-center double-blind randomized trial of celecoxib vs placebo in patients with breast cancer.
Advertisement
In this video, R. Charles Coombes, MD, PhD, of Imperial College London, United Kingdom, discusses results of REACT (Randomised European Celecoxib Trial), a phase III multi-center double-blind randomized trial of celecoxib vs placebo in patients with breast cancer.
Coombes presented results of this study (
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Dose Modification Strategies in EGFR Mutated Metastatic Non-Small Cell Lung Cancer
2
Utilizing AI Algorithms to Inform Breast Cancer Chemoprevention Strategies
3
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer
4
Orca-T May Be “Important Step Forward” in Hematologic Malignancy Care
5


























































